Edition:
United Kingdom

People: Dechra Pharmaceuticals PLC (DPH.L)

DPH.L on London Stock Exchange

2,894.00GBp
16 Aug 2019
Change (% chg)

6.00 (+0.21%)
Prev Close
2,888.00
Open
2,904.00
Day's High
2,942.00
Day's Low
2,880.00
Volume
129,625
Avg. Vol
172,877
52-wk High
3,166.00
52-wk Low
1,992.00

Sandland, Paul 

Mr. Paul Sandland, MAAT, FCCA, is Acting Chief Financial Officer, Executive Director of the Company. He was appointed as Group Financial Controller of Dechra and Finance Director of Dechra Laboratory Services and Dechra Specialist Laboratories in January 2010. He qualified as a Chartered Certified Accountant in 2005. Paul spent five years post qualification at KPMG, during which time he was part of the team which advised the Group on its acquisition of VetXX in 2008.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Tony Rice

126,000

Ian Page

3,536,000

Paul Sandland

--

Mike Eldred

--

Anthony Griffin

1,195,000

Katy Clough

--
As Of  30 Jun 2018